Does pregnancy affect the pharmacokinetics of efavirenz?

by Hill A., Ford N., Boffito M., Pozniak A., Cressey T.R.
Published 2014

Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis

by Ford, N., Kirby, C., Singh, K., Mills, E.J., Cooke, G., Kamarulzaman, Adeeba, duCros, P.
Published 2012

Expanding access to treatment for hepatitis C in resource-limited settings: Lessons from HIV/AIDS

by Ford, N., Singh, K., Cooke, G.S., Mills, E.J., Angerer, T.V.S., Kamarulzaman, A., Cros, P.D.
Published 2012

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phas...

by Tang M.W., Rhee S.-Y., Bertagnolio S., Ford N., Holmes S., Sigaloff K.C., Hamers R.L., De Wit T.F.R., Fleury H.J., Kanki P.J., Ruxrungtham K., Hawkins C.A., Wallis C.L., Stevens W., Van Zyl G.U., Manosuthi W., Hosseinipour M.C., Ngo-Giang-Huong N., Belec L., Peeters M., Aghokeng A., Bunupuradah T., Burda S., Cane P., Cappelli G., Charpentier C., Dagnra A.Y., Deshpande A.K., El-Katib Z., Eshleman S.H., Fokam J., Gody J.-C., Katzenstein D., Koyalta D.D., Kumwenda J.J., Lallemant M., Lynen L., Marconi V.C., Margot N.A., Moussa S., Ndung'U T., Nyambi P.N., Orrell C., Schapiro J.M., Schuurman R., Sirivichayakul S., Smith D., Zolfo M., Jordan M.R., Shafer R.W.
Published 2014